Evidence map›Paper›PMID 25743265›Full record

ArticleEndocrine2015

GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes.

Antonio Ceriello, Lucia La Sala, Valeria De Nigris, Gemma Pujadas, Roberto Testa, Annachiara Uccellatore, Stefano Genovese

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Endocrine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Antonio CerielloInstitut d' Investigación Biomédiques August Pi i Sunyer (IDIBAPS), C/Rosselló, 149-153, 08036, Barcelona, Spain. aceriell@clinic.ub.es.
Lucia La SalaInstitut d' Investigación Biomédiques August Pi i Sunyer (IDIBAPS), C/Rosselló, 149-153, 08036, Barcelona, Spain.
Valeria De NigrisInstitut d' Investigación Biomédiques August Pi i Sunyer (IDIBAPS), C/Rosselló, 149-153, 08036, Barcelona, Spain.
Gemma PujadasInstitut d' Investigación Biomédiques August Pi i Sunyer (IDIBAPS), C/Rosselló, 149-153, 08036, Barcelona, Spain.
Roberto TestaExperimental Models in Clinical Pathology, INRCA-IRCCS National Institute, Ancona, Italy.
Annachiara UccellatoreDepartment of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni, MI, Italy.
Stefano GenoveseDepartment of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni, MI, Italy.
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESMultiMedica · ITIstituto Nazionale di Riposo e Cura per Anziani · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntigens, CDDiabetes Mellitus, Type 1EndoglinFemaleGlucagon-Like Peptide 1HumansHyperglycemiaHypoglycemiaMaleMatrix Metalloproteinase 14Receptors, Cell SurfaceYoung AdultAntigens, CDEndoglinENG protein, humanGlucagon-Like Peptide 1Matrix Metalloproteinase 14Receptors, Cell Surface

Identifiers

PMID25743265
OpenAlexW2034899106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.